Product
Liposomal amphotericin B
3 clinical trials
4 indications
Indication
Cutaneous LeishmaniasisIndication
Native American myxoid fibrosarcomaIndication
MucormycosisIndication
Mucosal LeishmaniasisClinical trial
Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly: a Randomized Clinical TrialStatus: Completed, Estimated PCD: 2021-09-01
Clinical trial
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyStatus: Completed, Estimated PCD: 2009-12-01
Clinical trial
Treatment of Bolivian Mucosal Leishmaniasis With Miltefosine, Pentavalent Antimony or Liposomal Amphotericin BStatus: Recruiting, Estimated PCD: 2024-04-30